Clinical Factors Associated With Pediatric Brain Neoplasms
A study pinpointed clinical factors associated with pediatric brain neoplasms to assist clinicians in making neuroimaging decisions.
A study pinpointed clinical factors associated with pediatric brain neoplasms to assist clinicians in making neuroimaging decisions.
Treatment with lomustine plus bevacizumab does not show a survival advantage over treatment with lomustine alone in patients with glioblastoma.
1p/19q non-co-deleted anaplastic gliomas are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumors.
In patients with melanoma brain metastases, overall survival has increased since 2000.
The use of postoperative stereotactic radiosurgery could be a substitute for whole-brain radiotherapy, which has been linked to cognitive adverse effects.
Nearly half of the patients in the trial survived more than 5 years after they were given the vaccine-chemotherapy treatment.
Despite previous reports, researchers have found no signs of a link between cytomegalovirus and brain tumors including glioblastoma.
Molecular changes occur to cancer cells when they spread to the brain.
Radiomic-based superpc signature stratifies patients into low- or high-risk groups for PFS, OS.
Despite it being a standard of care, more or more pediatric patients are deferring PORT.